Novartis International has renewed its legal panel, with 22 firms making the cut on the new roster that has a particular focus on diversity and inclusion.

The Swiss multinational pharmaceutical company has reimagined the way it will collaborate with law firms with a new “preferred firms program” which puts firms making commitments to diversity an inclusion at an advantage.